// company-profile
Mineralys Therapeutics, Inc. Insider Trading
MLYSEvery SEC Form 4 insider trading filing for Mineralys Therapeutics, Inc. (MLYS) — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC.
curl "https://api.form4api.com/v1/transactions?ticker=MLYS" -H "X-Api-Key: YOUR_API_KEY"// activity-summary
Mixed insider activity over the last 30 days: 0 purchases and 0 sales (0 transactions total).
// 90-day insight
Over the last 90 days, Mineralys Therapeutics, Inc. insiders filed 50 Form 4 transactions, none of which were open-market purchases or sales.
- Most active insider: Rodman David Malcom with 38 transactions totaling $2.0M.
- Largest single sale: $2.7M by Warren Eric on Jun 26, 2026.
- 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of Mineralys Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 21, 2026 | Warren Eric | MLYS | Option Exercise10b5 | 7,438 | $0.00 | $0K |
| Jul 21, 2026 | Warren Eric | MLYS | Sale10b5 | 7,438 | $26.87 | $200K |
| Jul 21, 2026 | Warren Eric | MLYS | Option Exercise10b5 | 7,438 | $13.24 | $98K |
| Jul 17, 2026 | Rodman David Malcom | MLYS | Option Exercise10b5 | 416 | $0.00 | $0K |
| Jul 17, 2026 | Rodman David Malcom | MLYS | Sale10b5 | 416 | $26.53 | $11K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →